ID: ALA2336368

Max Phase: Preclinical

Molecular Formula: C8H11N11

Molecular Weight: 261.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  [N-]=[N+]=NCCn1cnc2c(NC(=N)N)nc(N)nc21

Standard InChI:  InChI=1S/C8H11N11/c9-7(10)15-5-4-6(17-8(11)16-5)19(3-13-4)2-1-14-18-12/h3H,1-2H2,(H6,9,10,11,15,16,17)

Standard InChI Key:  AQRJWLZVYNLHSD-UHFFFAOYSA-N

Associated Targets(Human)

Aurora kinase A/B 33 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MCF7 126967 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 2/cyclin E1 1877 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cyclin-dependent kinase 1/cyclin B1 1887 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 261.25Molecular Weight (Monoisotopic): 261.1199AlogP: 0.02#Rotatable Bonds: 4
Polar Surface Area: 180.28Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: 0HBA (Lipinski): 11HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: -10.29CX Basic pKa: 7.92CX LogP: -0.52CX LogD: -1.27
Aromatic Rings: 2Heavy Atoms: 19QED Weighted: 0.20Np Likeness Score: -0.48

References

1. Dolečková I, Cesnek M, Dračinský M, Brynda J, Voller J, Janeba Z, Kryštof V..  (2013)  Synthesis and biological evaluation of guanidino analogues of roscovitine.,  62  [PMID:23399722] [10.1016/j.ejmech.2013.01.021]

Source